Abstract
The impact of tumor-infiltrating B cells on breast cancer (BRCA) outcomes remains poorly understood. Recent findings from Yang et al. identify an atypical, clonally expanded population of activated Fc receptor-like 4 (FCRL4)+ B cells that is associated with improved overall survival in patients affected by various tumor types, including BRCA.
| Original language | English |
|---|---|
| Pages (from-to) | 990-991 |
| Number of pages | 2 |
| Journal | Trends in Cancer |
| Volume | 10 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ABCs
- CD8 cytotoxic T lymphocytes
- TNBC
- antigen presentation
- germinal center
- tertiary lymphoid structures
- Lymphocytes, Tumor-Infiltrating/immunology
- B-Lymphocytes/immunology
- Prognosis
- Humans
- Breast Neoplasms/immunology
- Female
Fingerprint
Dive into the research topics of 'Prognostic value of atypical B cells in breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver